Status:
COMPLETED
Framing Messages for Smoking Cessation With Bupropion - 6
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This is a randomized study of message framing in individuals beginning a smoking cessation program utilizing bupropion SR and brief counseling, videos, and pamphlets.
Eligibility Criteria
Inclusion
- Exclusion Criteria:
- Pregnant or nursing women, or women of child-bearing potential who are not using an adequate method of contraception
- Psychiatric illnesses requiring psychotropic medications (i.e., psychosis, major depression, mania), or the presence of suicidality or homocidality
- Current use of nicotine replacement therapies (i.e., nicotine patch, gum, or lozenges, nasal spray, or inhaler), bupropion (Zyban, Wellbutrin), or marijuana or current participation in another smoking cessation treatment
- Presence of unstable medical conditions (i.e., cardiac, hepatic, renal disease, diabetes mellitus) that would make a trial of bupropion SR hazardous
- Have taken monoamine oxidase inhibitors or metoprolol succinate within the past six weeks
- History of anorexia nervosa or bulimia
- Previous hypersensitivity to bupropion
- History of alcohol or other drug dependence in the past one year
- History of seizure disorder of any etiology (i.e., brain tumor, traumatic brain injury, substance-induced seizures, etc.)
- Any finding that in the view of the principal investigator would compromise the subject's ability to fulfill the protocol visit schedule and visit requirements or put the subject at risk
- Sharing home or work environment with current or past participant
- No couples or participants who see each other every day
Exclusion
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT00104598
Start Date
September 1 2000
End Date
December 1 2006
Last Update
August 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Substance Abuse Treatment Unit
New Haven, Connecticut, United States, 06519